Cipla (LUX:CIPLA) GF Score: 93/100 (As of Jul. 01, 2026) — Near Median


LUX:CIPLA Cipla Ltd LUX:CIPLA
93 GF Score
Price $18.10
GF Value $19.69
! 5 Warning Signs
View Full Analysis

What is Cipla GF Score?

Cipla LUX:CIPLA 93 GF Score is 93 as of Jul. 01, 2026, which is 2% below its 10-year median of 95.00. GuruFocus rates LUX:CIPLA with a GF Score™ of 93/100 and a GF Value™ of $19.69. The stock has 5 warning signs investors should review.

Cipla has the GF Score of 93, which implies that the company might have Highest outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 10/10
2. Profitability Rank : 9/10
3. Growth Rank : 10/10
4. GF Value Rank : 6/10
5. Momentum Rank : 5/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Cipla might have Highest outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Cipla  (LUX:CIPLA) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Cipla GF Score Related Terms

LUX:CIPLA vs ZTS, UTHR: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cipla GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's GF Score distribution charts can be found below:

* The bar in red indicates where Cipla's GF Score falls into.


LUX:CIPLA
93GF Score
Cipla Ltd LUX:CIPLA
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 93 mean?
Cipla (LUX:CIPLA) has a GF Score of 93 as of Jul. 01, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cipla and its competitors. This is near median its historical median of 95.00. Over the past decade, Cipla's GF Score has ranged from 34.00 to 100.00.
Is Cipla's GF Score too high?
Cipla's current GF Score of 93 is near median its 10-year median of 95.00. Over the past 10 years, this metric has ranged from a low of 34.00 to a high of 100.00. Overall, Cipla has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Cipla's GF Score compare to ZTS and UTHR?
Cipla's GF Score of 93 can be compared against companies in the Drug Manufacturers industry. Historically, Cipla's own GF Score has ranged from 34.00 to 100.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cipla and its competitors. Cipla's current GF Score is 93, which is near median its own 10-year median of 95.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Cipla (LUX:CIPLA) has a current GF Score of 93. The stock's GF Value™ is $19.69, compared to a current price of $18.10 — trading 8.1% below its estimated fair value. The current GF Score is 93, which is near median its 10-year median of 95.00. Cipla's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Cipla (LUX:CIPLA), the current GF Score is 93 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipla (LUX:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of $18.10 is trading 8.1% below its estimated GF Value™ of $19.69.

Key valuation signals for LUX:CIPLA:

  • GF Score: 93 (near median its 10-year median of 95.00)
  • GF Value™: $19.69 vs. price of $18.10 (8.1% below fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the LUX:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipla Business Description

Other Exchanges CIPLA:India500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
93GF Score

Get the complete analysis for LUX:CIPLA

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.10
Price
$19.69
GF Value